120 related articles for article (PubMed ID: 2156209)
1. The p53 nuclear localisation signal is structurally linked to a p34cdc2 kinase motif.
Addison C; Jenkins JR; Stürzbecher HW
Oncogene; 1990 Mar; 5(3):423-6. PubMed ID: 2156209
[TBL] [Abstract][Full Text] [Related]
2. p53 interacts with p34cdc2 in mammalian cells: implications for cell cycle control and oncogenesis.
Stürzbecher HW; Maimets T; Chumakov P; Brain R; Addison C; Simanis V; Rudge K; Philp R; Grimaldi M; Court W
Oncogene; 1990 Jun; 5(6):795-81. PubMed ID: 2141683
[TBL] [Abstract][Full Text] [Related]
3. Characterization of protein kinase activities associated with p53-large-T immune complexes from SV40-transformed rat cells.
Müller E; Boldyreff B; Scheidtmann KH
Oncogene; 1993 Aug; 8(8):2193-205. PubMed ID: 8393163
[TBL] [Abstract][Full Text] [Related]
4. p53 is associated with p34cdc2 in transformed cells.
Milner J; Cook A; Mason J
EMBO J; 1990 Sep; 9(9):2885-9. PubMed ID: 2167834
[TBL] [Abstract][Full Text] [Related]
5. Mouse p53 blocks SV40 DNA replication in vitro and downregulates T antigen DNA helicase activity.
Stürzbecher HW; Brain R; Maimets T; Addison C; Rudge K; Jenkins JR
Oncogene; 1988 Oct; 3(4):405-13. PubMed ID: 2856250
[TBL] [Abstract][Full Text] [Related]
6. A C-terminal alpha-helix plus basic region motif is the major structural determinant of p53 tetramerization.
Stürzbecher HW; Brain R; Addison C; Rudge K; Remm M; Grimaldi M; Keenan E; Jenkins JR
Oncogene; 1992 Aug; 7(8):1513-23. PubMed ID: 1321401
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of a protein kinase which is activated by SV40 large T-antigen and phosphorylates the tumor suppressor protein p53.
Müller E; Scheidtmann KH
Oncogene; 1995 Mar; 10(6):1175-85. PubMed ID: 7700642
[TBL] [Abstract][Full Text] [Related]
8. A novel system to investigate the phosphorylation of the p53 tumor suppressor protein by the protein kinase CK2.
McKendrick L; Meek DW
Cell Mol Biol Res; 1994; 40(5-6):555-61. PubMed ID: 7735330
[TBL] [Abstract][Full Text] [Related]
9. SV40 large T-antigen: dual oncogene.
Butel JS
Cancer Surv; 1986; 5(2):343-65. PubMed ID: 3022925
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of large tumour antigen by cdc2 stimulates SV40 DNA replication.
McVey D; Brizuela L; Mohr I; Marshak DR; Gluzman Y; Beach D
Nature; 1989 Oct; 341(6242):503-7. PubMed ID: 2552322
[TBL] [Abstract][Full Text] [Related]
11. The effects of SV40 large T antigen and p53 on nuclear transport capacity in BALB/c 3T3 cells.
Feldherr C; Cole C; Lanford RE; Akin D
Exp Cell Res; 1994 Jul; 213(1):164-71. PubMed ID: 8020587
[TBL] [Abstract][Full Text] [Related]
12. Structural aspects of the p53 protein in relation to gene evolution.
Soussi T; Caron de Fromentel C; May P
Oncogene; 1990 Jul; 5(7):945-52. PubMed ID: 2142762
[No Abstract] [Full Text] [Related]
13. An extended bipartite nuclear localization signal in Smad4 is required for its nuclear import and transcriptional activity.
Xiao Z; Latek R; Lodish HF
Oncogene; 2003 Feb; 22(7):1057-69. PubMed ID: 12592392
[TBL] [Abstract][Full Text] [Related]
14. Complex of simian virus large T antigen and p53 can bind DNA specifically.
Long SB; Ho HY; Chen CL; Lai MD
Anticancer Res; 1995; 15(4):1375-80. PubMed ID: 7654024
[TBL] [Abstract][Full Text] [Related]
15. Fine mapping and regulation of the association of p53 with p34cdc2.
Wagner P; Fuchs A; Götz C; Nastainczyk W; Montenarh M
Oncogene; 1998 Jan; 16(1):105-11. PubMed ID: 9467949
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase activity associated with immunopurified p53 protein.
Kraiss S; Barnekow A; Montenarh M
Oncogene; 1990 Jun; 5(6):845-55. PubMed ID: 2141685
[TBL] [Abstract][Full Text] [Related]
17. Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression.
Fiscella M; Ullrich SJ; Zambrano N; Shields MT; Lin D; Lees-Miller SP; Anderson CW; Mercer WE; Appella E
Oncogene; 1993 Jun; 8(6):1519-28. PubMed ID: 8502477
[TBL] [Abstract][Full Text] [Related]
18. Loss of a highly conserved domain on p53 as a result of gene deletion during Friend virus-induced erythroleukemia.
Munroe DG; Rovinski B; Bernstein A; Benchimol S
Oncogene; 1988 Jun; 2(6):621-4. PubMed ID: 3290808
[TBL] [Abstract][Full Text] [Related]
19. Post-translational modification of p53.
Meek DW
Semin Cancer Biol; 1994 Jun; 5(3):203-10. PubMed ID: 7948948
[TBL] [Abstract][Full Text] [Related]
20. The rate of nuclear cytoplasmic protein transport is determined by the casein kinase II site flanking the nuclear localization sequence of the SV40 T-antigen.
Rihs HP; Jans DA; Fan H; Peters R
EMBO J; 1991 Mar; 10(3):633-9. PubMed ID: 1848177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
